CRIP2 is considered to be a mitophagy-related gene in multiple myeloma, which can be used to predict the survival rate of multiple myeloma, and high CRIP2 expression is usually associated with poor prognosis [46]. The gene discussed is CRIP2; the disease is AL amyloidosis.